Results 31 to 40 of about 4,040,300 (192)

HIV-Prevalence Mapping Using Small Area Estimation in Kenya, Tanzania, and Mozambique at the First Sub-National Level

Annals of Global Health, 2021
Background: Local estimates of HIV-prevalence provide information that can be used to target interventions and consequently increase the efficiency of resources.
Enrique M. Saldarriaga
doaj   +1 more source

What is really uncovered by mixing different model structures: contrasts between latent class and model averaging

European Journal of Transport and Infrastructure Research, 2021
Latent class models have long been a tool for capturing heterogeneity across decisionmakers in the sensitivities to individual attributes. More recently, there has been increased interest in using these models to capture heterogeneity in actual ...
Thomas O Hancock, Stephane Hess
doaj  

COST-MINIMIZATION OF VILANTEROL / UMECLIDINIUM VERSUS OLODATEROL / TIOTROPIUM IN THE BASIC THERAPY OF SEVERE AND VERY SEVERE COPD

Фармакоэкономика, 2017
The recently introduced novel drug combinations for the treatment of COPD are based on long-acting beta-agonists (vilantererol / umeclidinum bromide) and long-acting anticholinergics (olodaterol / tiotropium bromide).
E. G. Kosolapov, F. S. Kochenkov, N. L. Pogudina, D. V. Blinov, N. L. Bondarenko, A. V. Karaulov   +5 more
doaj   +1 more source

Appraising patient preference methods for decision-making in the medical product lifecycle: an empirical comparison

BMC Medical Informatics and Decision Making, 2020
Background Incorporating patient preference (PP) information into decision-making has become increasingly important to many stakeholders. However, there is little guidance on which patient preference assessment methods, including preference exploration ...
Chiara Whichello, Bennett Levitan, Juhaeri Juhaeri, Vaishali Patadia, Rachael DiSantostefano, Cathy Anne Pinto, Esther W. de Bekker-Grob   +6 more
doaj   +1 more source

Sticky Categories and Their Negative Consequences: People with Learning Disabilities and ‘Behaviours that Challenge Others’

Scandinavian Journal of Disability Research
‘Behaviours that challenge others’ are attributed to 20% of people with learning disabilities. These behaviours are not a diagnosis, it is something people are labelled with.
Magdalena Mikulak, Sara Ryan, Elizabeth Tilley, Susan Ledger, Lisa Davidson, Pam Bebbigton, Dawn Wiltshire   +6 more
doaj   +1 more source

An Engel–Kollat–Blackwell model application on restaurant clientele purchase decision-making processes in commercial eateries in Kakamega County, Kenya

Research in Hospitality Management, 2023
Restaurant clientele have a task of making critical decisions concerning their choices of food and drinks. The decision-making process involves, firstly, the selection of the restaurant in which to have a meal and, secondly, the selection of food items ...
Simon O. Were
doaj   +1 more source

The treatment of infantile giant café au lait spot using golden parameter therapy with a high fluence 1064-nm Q-switched Nd: YAG laser

Journal of Dermatological Treatment
Background Infantile café au lait spot is a brown macule with various sizes (diameter: 0.5 cm–30 cm). Infantile giant café au lait spot (IGCALS) is a huge (diameter >20cm) irregular-shaped benign hyperpigmented skin disorder that arises in infants. There
Hoon Hur, Jin Ok Baek, Jae Seong Joo, Hojung Jung, Yu Ri Kim, Suk Jin Choi, Duck Taik Shim   +6 more
doaj   +1 more source

COMPARATIVE COST-MINIMIZATION AND BUDGET-IMPACT ANALYSIS OF FIXED-DOSE INHALED CORTICOSTEROID / LONG-ACTING BETAAGONIST COMBINATIONS IN THE TREATMENT OF ASTHMA

Фармакоэкономика, 2017
Comparative pharmacoeconomic analysis of fixed-dose combinations (FDC) vilanterol / fluticasone furoate vs budesonide / formoterol was needed to identify the preferable FDC for asthma management.Study objective: to identify the preferable FDC of inhaled ...
N. L. Pogudina, E. G. Kosolapov, F. S. Kochenkov, A. V. Karaulov, N. L. Bondarenko, D. V. Blinov   +5 more
doaj   +1 more source

Pharmacoeconomic analysis of using belimumab for the treatment of systemic lupus erythematosus

Фармакоэкономика, 2018
The aim is to study the clinical and economic aspects of using belimumab for the treatment of systemic lupus erythematosus (SLe) in patients with high SLe activity, the presence of anti-DNA, a low level of complement in the blood plasma and minimal lupus
A. G. Tolkushin, N. L. Pogudina
doaj   +1 more source

The effectiveness of nudging: A meta-analysis of choice architecture interventions across behavioral domains

Proceedings of the National Academy of Sciences of the United States of America, 2021
Significance Changing individuals’ behavior is key to tackling some of today’s most pressing societal challenges such as the COVID-19 pandemic or climate change.
S. Mertens, Mario Herberz, Ulf J. J. Hahnel, T. Brosch   +3 more
semanticscholar   +1 more source